Clinical Trial Update: CINC424A2X01B Rollover Protocol [Phase 4]

View source ↗

Summary

Phase 4 rollover protocol for CINC424A2X01B is active but not recruiting, spanning Primary Myelofibrosis, Polycythemia Vera, Graft-versus-host disease, Acute My…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Graft-versus-host Disease
• Myelofibrosis
• Polycythemia Vera
• Thalassemia

Drugs mentioned

• CINC424A2X01B

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Primary Myelofibrosis, Polycythemia Vera | Phase 4 | Status: ACTIVE_NOT_RECRUITING